A Study of LY3841136 in Japanese Participants With Obesity or Overweight
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about the side effects of LY3841136 alone and in combination with tirzepatide, when given to Japanese participants with obese or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Part A of the study will last about 28 weeks and may include up to 17 visits. Part B of the study will last about 40 weeks and may include up to 29 visits.